LEWATIT CNP-105
LEWATIT CNP 105 氢型
CAS No. 56940-15-9
LEWATIT CNP-105;LEWATIT CNP-105, H(+)-FORM, WEAKLY ACIDI C;Lewatit(R) CNP 105 hydrogen form
2,2'-Bipyridine, 4-methyl-4'-tridecyl- 85801-76-9
Oxazole, 4-(chloromethyl)-5-methyl-2-[4-(phenylmethoxy)phenyl]- 403611-86-9
4-Selenazolidinecarboxylic acid, 2-methyl-, (4R)- 403642-93-3
2,2'-Spirobi[bicyclo[2.2.1]hept-5-ene], 3-methyl- 403518-41-2
Propanoic acid, 3-[[(diethylamino)carbonyl]oxy]- 403616-97-7
OCTACHLORODIPHENYLOXIDE 40356-57-8
(prolyl-hydroxylprolyl-glycine)10 40350-90-1
Silane, (3,3-dimethylbutylidene)methylphenyl-, (E)- 85803-36-7
2-(2-FORMYL-6-METHOXYPHENOXY)ACETIC ACID 40359-30-6
9-Octadecenamide,N-[(1R)-2-methyl-1-[(phosphonooxy)methyl]propyl]-, (9Z)- 403520-13-8
Propanoyl fluoride, 2,2'-[1,2-ethanediylbis(oxy)]bis[3,3,3-trifluoro- 403482-65-5
2-METHOXYETHYLBENZENE 40356-59-0
1H-Pyrazole, 3-(4-chlorophenyl)-5-(2-furanyl)-4,5-dihydro-1-phenyl- 4035-38-5
1-(naphthalen-1-ylmethyl)-3-(2,4,5-trimethylphenyl)thiourea 4033-35-6
CYCLOBUTANECARBOXAMIDE,1-ACETYL- 403615-59-8
1,1':3',1''-Terphenyl,4,4''-bis[(1E)-2-(4-nitrophenyl)ethenyl]-5'-[4-[(1E)-2-(4-nitrophenyl)ethenyl]phenyl]- 403601-51-4
In.K.O.Si 403619-81-8
ASISCHEM N35533 40349-50-6
Methanediamine, N-methylene-1-(methylthio)-N'-phenyl- 403497-89-2
Phosphoramidothioic acid, O-butyl S-methyl ester 40334-23-4
3H-Pyrrole-3,3,4-tricarbonitrile,5-amino-1-(ethylideneamino)-1,2-dihydro-2-methyl- 85801-63-4
1(4H)-PYRIDINECARBOXYLIC ACID ETHYL ESTER 40339-63-7
Benzene, [(1,1,2,2-tetrafluoroethyl)thio]- 403-58-7
4-(3-BROMO-PROPYL)-PYRIDINE 40337-66-4
ACETIC ACID,(1,3,4-THIADIAZOL-2-YLOXY)- 40352-26-9
Acetic acid, [(5-methyl-1,3,4-thiadiazol-2-yl)oxy]- 40352-31-6
2-Propenoic acid, 3-methoxy-3-[(trimethylsilyl)oxy]-, methyl ester 40333-11-7
Propanoic acid, 3-hydroxy-2-methyl-, 2-ethylhexyl ester 403519-85-7
methyl 2-hydroxy-4-methylvalerate 40348-72-9
Methanone, [2-(5-bromo-3-pyridinyl)phenyl]-2-thienyl- 858035-61-7
L-Leucine,L-seryl-L-valyl-L-cysteinylglycyl-L-cysteinyl-L-prolyl-L-valylglycyl-L-histidyl-L-histidyl-L-a-aspartyl-L-valyl-L-valylglycyl- 403601-61-6
Oxirane,2-(1-methylethyl)-2-phenyl-, (2S)- 403501-36-0
RARECHEM AL BF 1252 4033-88-9
3-AMINO-4,5,6,7-TETRACHLORO-1-IMINO-1H-ISOINDOLE 40360-28-9
2-chloro-N-(2-chlorophenyl)-N-tert-butyl-prop-2-enimidamide 85801-96-3
[1,1'-Biphenyl]-4-carbonitrile, 2'-acetyl- 858035-57-1
2,1-Benzisothiazol-3(1H)-one 40352-87-2
(2E)-17-hydroxy-2-(hydroxymethylidene)androstan-3-one 4033-95-8
2,3,4,5-tetrahydro-1,5-benzothiazepine hydrobromide 40358-33-6
Cyclopentanecarboxamide,1-acetyl- 403615-60-1
1-Azabicyclo[4.2.0]octan-8-one, 7-phenyl-, (6R,7S)- 403502-85-2
D-Tyrosine, O-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-,pentafluorophenyl ester 403601-79-6
Cyclohexanone, 3,3'-(nitromethylene)bis- 403477-76-9
Ethanone, 1-[2-(1-naphthalenyl)phenyl]- 858035-58-2
1,2-Propanediaminium,N,N'-dihexadecyl-3-hydroxy-N,N,N',N'-tetramethyl-, dibromide 403609-17-6
Phenol, 4-(phenylmethoxy)-2-propyl- 403612-16-8
3,5-Hexadienoic acid, methyl ester 40338-61-2
Pentanoic acid,5-(2-fluorophenoxy)-3-[[(2S)-2-[[[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]acetyl]amino]-3-methyl-1-oxobutyl]amino]-4-oxo-, (3S)- 403499-19-4
Ethanone,1-[(1R,2R)-2-ethylcyclohexyl]- 403641-41-8
Nomate vantage 85800-68-6
2(1H)-Pyridinone, 4-methoxy-1,6-dimethyl- 40334-97-2
Ethanone,1-[(1R,2R)-2-ethylcyclopentyl]- 403641-40-7
N-(1-Isoquinolyl)-2,2-dimethylpropanamide 40339-93-3
2-Piperidinecarboxylicacid, 4-fluoro-, (2S,4S)- 403503-52-6
2-Methoxy-1,6-dimethyl-4-pyridone 40334-98-3
1,3-Benzenedisulfonic acid,5-[[[7-[[3-chloro-4-hydroxy-5-[(1-oxotridecyl)amino]phenyl]imino]-6-(1,1-dimethylethyl)-7H-pyrazolo[1,5-b][1,2,4]triazol-2-yl]amino]carbonyl]-,compd. with N,N-dioctyl-1-octanamine (1:1) 403602-72-2
3-hydroxypyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione 40338-57-6
Benzene, 1,1'-[1,3-propanediylbis(telluro)]bis[4-methoxy- 403491-34-9
[1,1'-Biphenyl]-2-carbonitrile, 2'-benzoyl- 858035-56-0
1,1-(1,10-Decanediyl)bisnaphthalene 40339-27-3